US Pharma’s Business Model: Why It Is Broken, and How It Can Be Fixed

The contents of this chapter are drawn from two contributions by the AcademicIndustry Research Network to the United Nations Secretary-General’s High-Level Panel on Access to Medicines: http://www.unsgaccessmeds.org/list-of-contribution/ William Lazonick is Professor of Economics, University of Massachusetts Lowell; Visiting Professor, University of Ljubljana; Professeur Associé, Institut MinesTélécom; and President.
Read more...

;